EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTPRD gene variant rs10739150: A potential game-changer in hypertension diagnosis

Laith Al-Eitan iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0304950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Laith Al-Eitan. Beteiligte Einrichtung: Department of Biotechnology and Genetic Engineering, Faculty of Science and Arts, Jordan University of Science and Technology, Irbid, Jordan. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Hypertension, Genetic Predisposition to Disease, Gene Frequency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Research, Jordan University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High blood pressure, also known as hypertension (HTN), is a complicated disorder that is controlled by a complex network of physiological processes. Untreated hypertension is associated with increased death incidence, rise the need for understanding the genetic basis affecting hypertension susceptibility and development. The current study sought to identify the genetic association between twelve single nucleotide polymorphisms (SNPs) within seven candidate genes ( NOS3 , NOS1AP , REN , PLA2G4A , TCF7L , ADRB1 , and PTPRD )

Methods

The current study included 200 Jordanian individuals diagnosed with hypertension, compared to 224 healthy controls. Whole blood samples were drawn from each individual for DNA isolation and genotyping. The SNPStats tool was used to assess haplotype, genotype, and allele frequencies by the mean of chi-square (χ2).

Results

Except for rs10739150 of PTPRD (P = 0.0003), the genotypic and allelic distribution of the SNP was identical between patients and controls. The prevalence of the G/G genotype in healthy controls (45.5%) was lower than in hypertension patients (64.3%), suggesting that it might be a risk factor for the disease. PTPRD TTC genetic haplotypes were strongly linked with hypertension (P = 0.003, OR = 4.03).

Conclusion

This study provides a comprehensive understanding of the involvement of rs10739150 within the PTPRD gene in hypertension. This new knowledge could potentially transform the way we approach hypertension diagnosis, providing an accurate diagnostic tool for classifying individuals who are at a higher risk of developing this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideHypertensionGenetic Predisposition to DiseaseGene FrequencyHaplotypesHumansFemaleMaleMiddle AgedAdultCase-Control StudiesReceptor-Like Protein Tyrosine Phosphatases, Class 2GenotypeJordanAlleles

Substanzen

PTPRD protein, humanReceptor-Like Protein Tyrosine Phosphatases, Class 2

Autor:innen und Institutionen

  • Department of Biotechnology and Genetic Engineering, Faculty of Science and Arts, Jordan University of Science and Technology, Irbid, Jordan.
  • Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA, United States of America.

ORCID-Profile: Laith Al-Eitan

Förderung

  • Deanship of Research, Jordan University of Science and Technology

Zitieren

APA

Al-Eitan, L. (2024). PTPRD gene variant rs10739150: A potential game-changer in hypertension diagnosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0304950

Vancouver

Al-Eitan L. PTPRD gene variant rs10739150: A potential game-changer in hypertension diagnosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0304950

BibTeX
@article{AlEitan2024,
  author = {Al-Eitan, Laith},
  title = {PTPRD gene variant rs10739150: A potential game-changer in hypertension diagnosis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0304950}
}
Kostenlos starten →